FIELD: medicine.
SUBSTANCE: invention concerns correction thromboplastingeneration at at patients with metabolic syndrome (MS). For this purpose within 6 months carry out the complex therapy including individually chosen hypohigh-calorie diet, rationally dosed out static and dynamic exercise stresses, and also introduction of preparations - Metforminum on 500 mg 2 times a day after meal, Valsartan 80 mg - 1 time a day and Rozuvastatin 10 mg in the evening.
EFFECT: effective correction of thromboplastinopoiesis at patients with MS at the expense of potentiation of therapeutic effect of separate components of complex therapy.
1 ex
